Lucid Diagnostics Inc. Stock Analysis & AI Score
Lucid Diagnostics Inc. (LUCD) has an ST Score of 37.0 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $2.00 price target (+138.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Lucid Diagnostics Inc. (LUCD) has an ST Score of 37.0 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $2.00 price target (+138.7% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- ValuationB-
- GrowthC
- Financial StrengthD+
- MomentumD
- ProfitabilityF
- Piotroski3/9
Contact
LUCD stock: frequently asked questions
What is LUCD's ST Score?
Lucid Diagnostics Inc. (LUCD) has an ST Score of 37.0 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LUCD a buy, hold, or sell?
Analysts rate LUCD a Buy, with a price target of $2.00 (+138.7% vs the current price). Our ST Score grades it C (37.0/100). The ST Score is a data-driven signal, not a recommendation.
What are LUCD's factor grades?
Valuation B-, Profitability F, Financial Strength D+, Momentum D, Growth C, Forecast A.
What is LUCD's valuation grade?
Lucid Diagnostics Inc. (LUCD) earns a valuation grade of B-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LUCD's growth grade?
Lucid Diagnostics Inc. (LUCD) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LUCD's profitability grade?
Lucid Diagnostics Inc. (LUCD) earns a profitability grade of F, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LUCD's financial strength grade?
Lucid Diagnostics Inc. (LUCD) earns a financial strength grade of D+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LUCD?
The average analyst price target for Lucid Diagnostics Inc. (LUCD) is $2.00 from 6 analysts, which is +138.7% versus the recent price of $0.84.
What is LUCD's Piotroski score?
Lucid Diagnostics Inc. (LUCD) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.